Investigating In Vitro and Ex Vivo Properties of Artemether/Lumefantrine Double-Fixed Dose Combination Lipid Matrix Tablets Prepared by Hot Fusion.

Wilkins, Christi A; du Plessis, Lissinda H; Viljoen, Joe M

Wilkins, Christi A; du Plessis, Lissinda H; Viljoen, Joe M.

Afiliación

Wilkins CA; Centre of Excellence for Pharmaceutical Sciences (PharmacenTM), Building G16, North-West University, 11 Hoffman Street, Potchefstroom 2520, South Africa.
du Plessis LH; Centre of Excellence for Pharmaceutical Sciences (PharmacenTM), Building G16, North-West University, 11 Hoffman Street, Potchefstroom 2520, South Africa.
Viljoen JM; Centre of Excellence for Pharmaceutical Sciences (PharmacenTM), Building G16, North-West University, 11 Hoffman Street, Potchefstroom 2520, South Africa.

Pharmaceutics ; 13(7)2021 Jun 22.

Article en En | MEDLINE | ID: mdl-34206248

Palabras clave

artemether; biorelevant media; dissolution; double-fixed dose combination; hot fusion; lipid-based formulations; lumefantrine; solid lipid dispersion

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google